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Available online 3 August 2016AbstractPurpose: To present a rare presentation of optic nerve glioma (ONG) with total intraocular extension.
Methods: A 44-year-old man with a history of loss of vision since childhood and recent development of progressive disfiguring proptosis was
referred.
Results: The vision in the affected eye was no light perception, and a proptosis of about 2e3 mm was present. Computed tomography and
Magnetic Resonance Imaging (MRI) of brain/orbit showed a fusiform enlargement of the left optic nerve and total filling of vitreous cavity by a
mass with high signal intensity in T2-weighted MRI. There was no extension into the intracranial cavity. The patient also had no signs of
neurofibromatosis. Histopathology confirmed the diagnosis of ONG of the left orbit with extension into the globe and filling vitreous cavity.
Conclusion: ONG may extend to the vitreous cavity with no simultaneous intracranial involvement.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Optic nerve glioma (ONG) is the most common primary
tumor of the optic nerve and is usually detected during the first
decade of life. The characteristic of ONG is indolent growth
with alternating periods of inactivity and growth with rare
cases of spontaneous tumor regression.1 It usually occurs in
the extra-ocular region of the optic nerve.2 ONG arises pre-
dominantly between the globe and the orbital apex. The tumor
usually remains confined to the orbit or occasionally extends
toward the orbital apex with subsequent involvement of theNo Conflict of interest was declared. No financial support received for this
submission.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).chiasm and other parts of brain such as the hypothalamus. To
the best of our knowledge, only a handful of cases of ONG
with intraocular extension have been reported.3e5
Herein, we present a 44-year-old man with an ONG
extended into the globe filling the vitreous cavity.
Case report
The patient was a 44-year-old man with a history of loss of
vision since childhood. He did not seek medical assistance
until the age of 44, when he developed proptosis and eye
disfigurement progressively (Fig. 1A). The affected eye had no
light perception. In ophthalmologic examination, the right eye
had no remarkable pathology, but the left eye had about
2e3 mm proptosis measured by exophthalmometer. In slit
lamp examination, he had whitish opacification of the cornea.
Scleral thinning and blue hue from uveal tissue were also seen.
However, details of anterior chamber, lens, and posteriorosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
Fig. 1. A: Left eye disfigurement. B: Orbital CT scan shows fusiform enlargement of optic nerve and tumor occupying vitreous cavity with calcification. C: sagittal
brain MRI T2 weighted. D: Axial post-contrast T1 weighted MRI with fat suppression. C and D show extent of the tumor and absence of intracranial extension.
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Computerized tomography (CT) scan and Magnetic Reso-
nance Imaging (MRI) showed a fusiform mass behind the
globe with high intensity signal in T2 weighted images (Fig. 1,
BeD) which is characteristic of ONG.3
Enucleation was performed. The globe and retrobulbar
mass were excised and underwent histopathological evalua-
tion. Gross evaluation of the specimen revealed smooth and
fusiform enlargement of the optic nerve as well as a homog-
enous solid mass filling almost all of the vitreous cavity
(Fig. 2).
Microscopic examination of the Hematoxylin & Eosin
slides of the tumor under light microscope (Olympus, Model
BX51) showed a coarsely reticulated and myxomatous pattern
of spindle-shaped cells, some of which contained cytoplasmic
eosinophilic structures compatible with Rosenthal fibers
(Fig. 3A, B) as well as areas of mucinous material accumu-
lation (Fig. 3C) and presence of focal calcification that is a
sign of long-lasting tumor (Fig. 3D). The tumor was juvenile
pilocytic astrocytomas, grade I, according to the World Health
Organization (WHO) classification. Complete effacement ofFig. 2. Complete filling of vitreous cavity by tumor.the optic nerve and vitreous cavity by the tumor was noted
(Fig. 2). Furthermore, there was atrophy of iris and absence of
normal retina which was completely replaced by the tumor,
even though the choroidal tissue was present somewhere
(Fig. 3D). Immunostaining demonstrated that the tumor cells
were positive for Glial fibrillary acidic protein (GFAP), S100
(focal), and vimentin, negative for cytokeratin, HMB 45, and
synaptophysin, and the Ki67 index was low (Fig. 3, EeF).
The patient was evaluated for signs of neurofibromatosis
such as cutaneous pigmented macules (cafe-au-lait spots),
neurofibromas, iris (Lisch) nodules, and osseous defects
involving the orbit. However, no sign was found. There was no
sign of recurrence during 9 months of follow-up examinations,
and prosthetic eye was successfully fitted. Written informed
consent was obtained from the patient.
Discussion
Our patient was a neglected case of ONG with intraocular
involvement. Sporadic optic pathway gliomas (OPGs) typi-
cally present before age 8. Onset can also occur in the second
decade. Presentation of new symptomatic sporadic OPGs in
older adults up to the fifth decade have been reported occa-
sionally.6 In contrast, malignant optic gliomas of adulthood
usually presented with sudden acute visual loss may be
associated with neurological symptoms, and it is rare for
them to result in proptosis.1 Our patient had a history of loss
of vision since childhood without seeking medical assistance
until the age of 44, when he developed progressive proptosis
and eye disfigurement. We think this patient may be a
neglected childhood benign ONG. However, presentation of
a new benign ONG in an older adult is another possibility.
The remarkable feature of our case is the rare complete
intraocular involvement of the ONG. ONG presenting with
Fig. 3. Microphotographs of histopathologic and immunohistochemical analysis. (A) Coarsely reticulated and myxomatous pattern of spindle-shaped cells. (H & E
100). (B) Cytoplasmic eosinophilic structures (Rosenthal fibers). (H & E,1000). (C) Areas of mucinous material accumulation. (H & E, 200). (D) Choroidal
tissue was present somewhere. (H & E, 100). (E) The tumor was immunoreactive to GFAP. (100). (F) Ki67 immunoreactivity was <1%. (100).
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neurofibromatosis has been reported previously.4 ONG with a
manifestation of an elevated oval optic disc mass with
extension into the retina has also been reported.5 However, as
the authors have demonstrated, no actual invasion of the
vitreous by tumor was noted, and the hyaloid membrane was
intact over the tumor.5 Recently, another case of OPG with
intraocular optic nerve involvement in a 3-year-old girl with
neurofibromatosis was published.3 Our patient is the first
report in literature of ONG with complete intraocular
extension filling almost all the vitreous cavity in a patient
without neurofibromatosis. In addition, this case is the first
report of ONG with intraocular extension filling vitreous
cavity presenting in an older adult. This case report presents
a patient who lost all useful vision in his eye due to the late
referral for ophthalmological examination. Clinical pre-
sentations of ONG are most often vision loss andexophthalmos,7 which were observed in our case. Since the
tumor is often located completely within the muscle cone and
tumor progression is slow, other symptoms such as pain,
inflammation, or ophthalmoplegia are only reported in pa-
tients with very large tumors.7 Tumors may progress toward
the globe or orbital apex or both, and only rarely affect
intraocular structures.8,9
Neurofibromatosis-1 (NF1) has been observed in approxi-
mately 25% (range: 10e70%) of cases.1 Our patient had no
signs of NF1.
The best treatment plan for patients with ONG is still
controversial.10 The complexity of the disease requires indi-
vidualized specific interventional strategies.7 In conclusion,
ONG should be considered a differential diagnosis in patients
with intraocular mass and proptosis. It may present even as a
complete intraocular tumor filling almost all the vitreous
cavity.
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